nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
|
Li, Wang |
|
|
10 |
12 |
p. 840-841 |
artikel |
2 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
|
Kjeldsen, Sverre E |
|
|
10 |
12 |
p. 840 |
artikel |
3 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes – Authors' reply
|
Nazarzadeh, Milad |
|
|
10 |
12 |
p. 841-842 |
artikel |
4 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye |
|
|
10 |
12 |
p. 837-839 |
artikel |
5 |
Diabetes education: the key to a brighter tomorrow
|
The Lancet Diabetes & Endocrinology, |
|
|
10 |
12 |
p. 827 |
artikel |
6 |
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
|
Inzucchi, Silvio E |
|
|
10 |
12 |
p. 869-881 |
artikel |
7 |
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
|
Haqq, Andrea M |
|
|
10 |
12 |
p. 859-868 |
artikel |
8 |
Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis
|
Ward, Zachary J |
|
|
10 |
12 |
p. 848-858 |
artikel |
9 |
Gestational diabetes in Australia: navigating a tsunami
|
McIntyre, H David |
|
|
10 |
12 |
p. 846-847 |
artikel |
10 |
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
|
Avogaro, Angelo |
|
|
10 |
12 |
p. 882-889 |
artikel |
11 |
Lorenz Hofbauer: connecting the unexpected
|
Burki, Talha |
|
|
10 |
12 |
p. 844 |
artikel |
12 |
Open-source automated insulin delivery in type 1 diabetes—the evidence is out there
|
Hussain, Sufyan |
|
|
10 |
12 |
p. 835-836 |
artikel |
13 |
Prequalification of insulin: what is missing?
|
Beran, David |
|
|
10 |
12 |
p. 842-843 |
artikel |
14 |
Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status
|
Gerstein, Hertzel C |
|
|
10 |
12 |
p. 831-832 |
artikel |
15 |
Setmelanotide for controlling weight and hunger in Bardet-Biedl syndrome
|
Tauber, Maithe |
|
|
10 |
12 |
p. 829-830 |
artikel |
16 |
Social media and misinformation in diabetes and obesity
|
Burki, Talha |
|
|
10 |
12 |
p. 845 |
artikel |
17 |
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news
|
Nappi, Rossella E |
|
|
10 |
12 |
p. 832-834 |
artikel |
18 |
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
|
Khunti, Kamlesh |
|
|
10 |
12 |
p. 890-900 |
artikel |
19 |
Trending now: modelling global epidemiology of type 1 diabetes in children and adolescents
|
Stene, Lars C |
|
|
10 |
12 |
p. 828-829 |
artikel |